Medicom Technologies Named as a Sample Vendor in Two Gartner® Hype Cycle™ Reports
RALEIGH, N.C., Sept. 18, 2023 /PRNewswire/ -- For the second consecutive year, Medicom Technologies, Inc. (Medicom) proudly announces its inclusion as a Sample Vendor in two highly anticipated Gartner Hype Cycle reports for Health Care and Life Sciences (HCLS) organizations. The recently published reports in July 2023 showcase Medicom's instrumental role in the evolving landscape of data monetization within the healthcare sector. Medicom is featured in the Gartner Hype Cycle for Healthcare Data, Analytics, and AI, 2023, as well as the Gartner Hype Cycle for Life Science Clinical Development, 2023.
Medicom's repeat inclusion as a Sample Vendor in these reports serves as a testament to its pivotal role in facilitating groundbreaking research aimed at improving patient outcomes. Through Medicm Intellect, the healthtech company's suite of solutions specializing in the curation and de-identification of longitudinal datasets, research partners provide Real World Data (RWD) for critical initiatives such as AI and machine learning endeavors, academic research, and therapeutic development.
Medicom's innovative approach empowers both academic research institutes and healthcare companies to streamline their workflows efficiently and cost-effectively. This enables them to search, locate, and de-identify health data internally and across organizations, advancing research and development (R&D) efforts. Within this ecosystem, Medicom leverages its extensive nationwide health network, Medicom Connect, as a secure conduit for trusted access to medical imaging and related clinical data.
Traditionally, R&D initiatives within the HCLS sector have relied on labor-intensive, time-consuming manual processes to produce desired research outcomes. Through the relationship between Medicom Connect and Medicom Intellect, HCLS organizations adopt more efficient research workflows to accelerate bringing valued therapeutics to market.
Both Gartner Hype Cycle reports place data monetization in HCLS near Main Street adoption as early as 2025, sharing "The absolutist stigma that has prevented many healthcare organizations from pursuing monetization initiatives have eased. This is a result of widely publicized data-selling practices across industries, demonstrable benefit of shared data to medical science and policy research, and the time data monetization practices have been a part of the healthcare market."
Medicom is committed to driving innovation and positive change in the HCLS sector, and its continued recognition by Gartner is a testament to the company's dedication to advancing the future of healthcare through data-driven solutions.
Download your complimentary Gartner Report here.
About Medicom: Medicom is a healthtech company dedicated to creating innovative solutions for patients, health systems, and life sciences. Data and insights from the Medicom Network help clinicians and researchers advance patient care and develop new therapies.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
View original content to download multimedia:https://www.prnewswire.com/news-releases/medicom-technologies-named-as-a-sample-vendor-in-two-gartner-hype-cycle-reports-301930813.html
SOURCE Medicom Technologies, Inc.
ITEXPO #TECHSUPERSHOW Booth Crawl
Solutions Showcase Session
Capitalizing on 5G for Revenue Growth